Share
 
Title
Code
Session Type
Venue
Date Time
Chair:

This multi-perspective session takes stock of trends in the pricing of medications and diagnostics that are essential for the prevention and treatment of HIV and its comorbidities. As new treatment guidelines expand the number of individuals who need treatment and governments consider the costs of bolder responses to the epidemic, the prices of medicines and pharmaceuticals are likely to play an increasingly important role. The session discusses and analyses recent controversies over the pricing of medications and diagnostics, neglected areas in which greater development is needed, and policies that promote or hinder access. Directed towards policymakers, programme managers, advocates and community representatives, it also includes discussion of emerging issues and offers perspectives from the industry, donor organizations, and low- and middle-income countries. At the end of the session, participants will understand issues related to the pricing of pharmaceuticals and be able to identify the various forces shaping prices.

16:30
WEBS0301
Introduction

16:35
WEBS0302
Recent trends in prices of antiretrovirals and diagnostics
Sharonann Lynch, Doctors without Borders, United States
Slides

16:50
WEBS0303
Role of national intellectual property laws and regulatory practices: examples from India, Brazil and South Africa
Umunyana Rugege, Section 27, South Africa
17:05
WEBS0304
Perspective from industry
Anil Soni, Mylan, United States
17:20
WEBS0305
Patents and access to medicines: a civil society perspective from eastern Europe
Andriy Klepikov, International HIV/AIDS Alliance, Ukraine
Slides

17:35
WEBS0306
Questions and answers
17:50
WEBS0307
Concluding remarks
Naledi Pandor, Minister of Science and Technology, South Africa